Moderate coffee and tea consumption is associated with slower cognitive decline
Journal of Alzheimer’s Disease · 2025-09 · 107 (1) · 170-178
DOI: 10.1177/13872877251361058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 21.07.2025. Verfasst von Stephanie R Rainey-Smith und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia. Hauptthemen laut MEDLINE: Coffee, Tea, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Health and Medical Research Council, Western Australian Near-Miss Award.
Abstract (Originalsprache)
Background
Globally, coffee and tea are consumed extensively, potentially providing neuroprotection through anti-inflammatory and antioxidative stress effects.
Objective
This study aimed to investigate associations between coffee and tea intake and cognitive function.
Methods
In a longitudinal prospective cohort study, dementia-free ( n = 8715; age range 60.0–85.2 years) older adults from the UK Biobank self-reported coffee and tea intake over the previous year; ‘never’, ‘moderate’ (1–3 cups/day), or ‘high’ (≥4 cups/day). Participants completed cognitive assessments at ≥2 timepoints (mean of 9.11 years).
Results
Those ‘never’ consuming coffee and ‘moderate’ coffee consumers ( β = 0.06, p = 0.005; β = 0.07, p < 0.001, respectively), as well as ‘moderate’ tea consumers and ‘high’ tea consumers ( β = 0.06, p = 0.009; β = 0.06, p = 0.003, respectively) had slower fluid intelligence decline. Additionally, those ‘never’ consuming coffee and ‘moderate’ coffee consumers had a slower increase in pairs matching errors (β = −0.05, p = 0.022; β = 0.05, p = 0.013) compared to ‘high’ consumers. Conclusions ‘ Moderate’ coffee, and ‘moderate’ and ‘high’ tea intake may be a protective factor against cognitive decline. Randomized controlled trials are required to establish causal relationships leading to evidence-based recommendations regarding benefits of coffee and tea intake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia.
- School of Psychological Science, University of Western Australia, Perth, Western Australia, Australia.
- Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
- Alzheimer's Research Australia, Ralph and Patricia Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia.
- Lifestyle Approaches Towards Cognitive Health Research Group, Murdoch University, Murdoch, Western Australia, Australia.
- AdventHealth Research Institute, Neuroscience, Orlando, FL, USA.
ORCID-Profile: Samantha L Gardener
Förderung
- The National Health and Medical Research Council
- Western Australian Near-Miss Award
Zitieren
APA
Rainey-Smith, S. R., Sewell, K. R., Brown, B. M., Sohrabi, H. R., Martins, R. N., & Gardener, S. L. (2025). Moderate coffee and tea consumption is associated with slower cognitive decline. Journal of Alzheimer’s Disease, 107(1), 170-178. https://doi.org/10.1177/13872877251361058
Vancouver
Rainey-Smith SR, Sewell KR, Brown BM, Sohrabi HR, Martins RN, Gardener SL. Moderate coffee and tea consumption is associated with slower cognitive decline. Journal of Alzheimer’s Disease. 2025;107(1):170-178. doi:10.1177/13872877251361058
BibTeX
@article{RaineySmith2025,
author = {Rainey-Smith, Stephanie R and Sewell, Kelsey R and Brown, Belinda M and Sohrabi, Hamid R and Martins, Ralph N and Gardener, Samantha L},
title = {Moderate coffee and tea consumption is associated with slower cognitive decline},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
volume = {107},
number = {1},
pages = {170--178},
doi = {10.1177/13872877251361058}
}
EUVIMED